Inspira Technologies Granted Japanese Patent For Co's INSPIRA ART System's Convertible Dual Lumen Cannula Device, Method Of Use

The patent grants Inspira exclusive commercial rights in the patented Dual Lumen Cannula technology in Japan through 2041. This milestone complements the Company's existing U.S. Patent (granted in 2023), further enhancing a unified protective barrier across two of the world's largest healthcare economies. Strategically, this IP supports the potential standalone commercialization of the cannula as a high-value disposable product, in addition to its integration into the INSPIRA™ ART System.